Amanote Research
Register
Sign In
Treatment of Newly Diagnosed Central Nervous System (CNS) Lymphoma Patients Based on Co-Morbidities & Performance Status: A Single-Centre Experience
Hematological Oncology
- United Kingdom
doi 10.1002/hon.2439_104
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2017
Authors
Y. Lim
J. Smith
Publisher
Wiley
Related search
Chronic Lymphocytic Leukemia Involvement of Central Nervous System: A Single Centre Experience
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Serum VEGF-A Concentrations in Patients With Central Nervous System (CNS) Tumors
PLoS ONE
Multidisciplinary
Primary Central Nervous System Lymphoma
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Primary Central Nervous System Lymphoma
Contemporary Neurosurgery
Primary Central Nervous System Lymphoma
Journal of Neurosurgery
Surgery
Neurology
Primary Central Nervous System Lymphoma: A Curable Disease
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Drugs Acting on Central Nervous System (CNS) Targets as Leads for Non-CNS Targets
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma
Neurology
Neurology